Canovas Nunes, Sara http://orcid.org/0000-0002-5582-0773
De Vita, Serena
Anighoro, Andrew
Autelitano, François http://orcid.org/0000-0001-6269-2629
Beaumont, Edward
Klingbeil, Pamela
McGuinness, Meaghan
Duvert, Beatrice
Harris, Chad
Yang, Lu
Pokharel, Sheela Pangeni
Chen, Chun-Wei http://orcid.org/0000-0002-8737-6830
Ermann, Monika
Williams, David A. http://orcid.org/0000-0001-7057-6863
Xu, Haiming
Funding for this research was provided by:
Alex’s Lemonade Stand Foundation for Childhood Cancer (19-16300)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (5R01CA202756)
Article History
Received: 1 November 2021
Accepted: 28 March 2022
First Online: 14 April 2022
Competing interests
: DAW has been funded by the NIH. He is or was recently a member on a Board of Directors or advisory committees for: Bluebird bio, Orchard Therapeutics, Novartis, Beam Therapeutics, Emerging Therapy Solutions, Geneception, and BioMarin. In addition, he is the Co-founder of Alerion Biosciences and Orchard Therapeutics. AA, FA, EB, PK, and ME declare present or past employment by Evotec while engaged in the research project. SDV declares present employment by Novartis Institute for Biomedical Research. The remaining authors declare no competing interests.